4 completed, 2 active not recruiting, 2 not yet recruiting, 2 unknown. 6 Phase 2, 4 Not applicable, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 2, Not yet recruiting 2, Terminated 1, Unknown 1 |
| Not applicable | 4 | Active not recruiting 2, Recruiting 1, Unknown 1 |
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow BEAM: new trials by email Literature Review of BEAM trials Research Report on BEAM
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalized Ultrasonic Brain Stimulation for Fibromyalgia Low-intensity ultrasound brain stimulation, Sham (No Treatment) - Fibromyalgia (FM) | Not applicable | Recruiting | University of Utah | 50 | 2026-01-05 | 2026-01-23 |
| Emotional Intelligence Intervention to Improve Mental Well-Being of Adolescents With Emotional Distress (BEAM) BEAM - Emotional Distress | Not applicable | Active not recruiting | Consorci Sanitari de Terrassa | 104 | 2025-04-07 | 2026-05-14 |
| Selinexor Combined With BEAM for ASCT in R/R DLBCL With MYC Positive selinexor combined with BEAM regimen, BEAM regimen - Diffuse Large B Cell Lymphoma | Phase 2 | Not yet recruiting | Ruijin Hospital | 82 | 2024-11-01 | 2024-10-22 |
| Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL zanubrutinib combined with BEAM, BEAM - DLBCL | Phase 2 | Not yet recruiting | Ruijin Hospital | 66 | 2024-11-01 | 2024-10-22 |
| Evaluation of Bariatric Endoscopic Antral Myotomy (BEAM) as a Treatment for Obesity Bariatric Endoscopic Antral Myotomy - Obesity, Weight Loss | Not applicable | Active not recruiting | Brigham and Women's Hospital | 20 | 2024-02-21 | 2026-06-25 |
| Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT modified BEAM, BEAM - Autologous Stem Cell Transplantation, Conditioning | Not applicable | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 122 | 2023-04-15 | 2023-04-18 |
| A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial) BeEAM, BEAM - Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular | Phase 2 | Completed | Insel Gruppe AG, University Hospital Bern | 108 | 2015-04-01 | 2025-08-01 |
| A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL) ZEVALIN, BEAM - Relapsed Follicular Lymphoma | Phase 3 | Completed | Fondazione Italiana Linfomi - ETS | 159 | 2012-01-01 | 2026-09-09 |
| Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma Auto stem cell transplant, BEAM, 111In-daclizumab - Hodgkin Disease, Hodgkin Lymphoma | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 6 | 2011-10-11 | 2021-10-06 |
| Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma Immunochemotherapy, High-dose BEAM plus autologous SCT, HLA-identical allogenic SCT - Mantle-Cell Lymphoma | Phase 2 | Unknown | Heidelberg University | 20 | 2004-07-01 | 2009-07-27 |
| Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma Rituxan, BEAM, Autologous stem cell transplant - Lymphoma | Phase 1 / Phase 2 | Completed | University of Nebraska | 32 | 1998-05-12 | 2023-09-07 |
| Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's Lymphoma 131Iodine-Anti-B1 Radioimmunotherapy, BEAM - Lymphoma | Phase 1 | Completed | University of Nebraska | 34 | 1996-03-04 | 2023-10-10 |
Lymphoma, Follicular (3) · Lymphoma (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Mantle-Cell (2) · Lymphoma, Non-Hodgkin (2) · Dendritic Cell Sarcoma, Interdigitating (1) · Fibromyalgia (1) · Hodgkin Disease (1) · Obesity (1) · Obesity, Morbid (1) · Psychological Well-Being (1) · Weight Loss (1)
Ruijin Hospital (2) · University of Nebraska (2) · Brigham and Women's Hospital (1) · Consorci Sanitari de Terrassa (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · Fondazione Italiana Linfomi - ETS (1) · Heidelberg University (1) · Insel Gruppe AG, University Hospital Bern (1) · National Cancer Institute (NCI) (1) · University of Utah (1)
United States (5) · Austria (1) · China (1) · Germany (1) · Italy (1) · Spain (1) · Switzerland (1)
Julie M Vose, MD (2) · Akiko Okifuji, PhD (1) · Anthony D. Ho, Ph.D., Prof. (1) · Christopher C. Thompson, MD, MSc (1) · Felix Keil, Prim. Univ. Prof. Dr (1) · Kevin C Conlon, M.D. (1) · Marco Ladetto (1) · Maria Llistosella, PhD (1) · Thomas Pabst, Prof Dr. med (1) · Umberto Vitolo (1) · Xiaoning Wang (1)
PMID 10673703, PMID 21816830, PMID 23749106, PMID 24005886, PMID 24591201, PMID 30555393, PMID 31316419, PMID 37922989, PMID 38024477, PMID 39073370, PMID 39755367, PMID 42103371, PMID 7477169
2014 (1)